SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $322,000 | -82.3% | 3,300 | -83.2% | 0.00% | -75.0% |
| Q4 2014 | $1,819,000 | +78.7% | 19,600 | +32.4% | 0.00% | +33.3% |
| Q3 2014 | $1,018,000 | +31.2% | 14,800 | +100.0% | 0.00% | +50.0% |
| Q2 2014 | $776,000 | +66.9% | 7,400 | +32.1% | 0.00% | +100.0% |
| Q1 2014 | $465,000 | -85.8% | 5,600 | -89.2% | 0.00% | -91.7% |
| Q3 2013 | $3,279,000 | +609.7% | 51,800 | +370.9% | 0.01% | +500.0% |
| Q2 2013 | $462,000 | +95.8% | 11,000 | +115.7% | 0.00% | +100.0% |
| Q4 2012 | $236,000 | – | 5,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|